George Washington University to Conduct Clinical Trial for COVID-19 Experimental Vaccine
GW has been selected as one of approximately 90 sites in the U.S. to participate in clinical trials of experimental vaccines.
GW has been selected as one of approximately 90 sites in the U.S. to participate in clinical trials of experimental vaccines.
Testing begins Monday, April 6, and will only be conducted by appointment, after a physician has spoken with the patient.